7 Best Identity Verification Providers for Telehealth in 2026

Identity verification providers for telehealth need to work for the patient who cannot get through, as well as the one who completes every step first time.

A patient has found the right appointment, filled out the form and reached the identity check. Their phone will not capture the document. What happens next?

That moment deserves as much attention as the successful signup. Didit is our first pick for evaluating onboarding and returning-patient verification. For a care service, though, the shortlist remains provisional until the contract, handling of patient information and route to human assistance are resolved.

There are three questions to keep separate: who is using the account, whether they can access a particular record, and whether that record belongs to the intended patient. A document-and-selfie check helps with the first. The product, privacy, security and care teams still need to work through the other two. The regulatory discussion here focuses on the United States.

Compare the reason to investigate each provider

Didit, Persona and Jumio each publish healthcare-specific material. Use it to prepare a conversation about the actual patient journey: what happens at registration, what changes on a return visit, and who helps when verification fails. An advertised agreement is a useful starting point; the signed scope must fit the service.

1. Didit: best starting point for onboarding and return visits

Didit is our first pick for a telehealth identity evaluation because it addresses both the initial registration and the returning patient. Its telehealth offering pairs onboarding with biometric reauthentication, listed separately at $0.10 per authentication. That gives a care team two distinct journeys to design, rather than making a full document check the answer to every visit.

The core onboarding bundle is $0.33 after eligible allowances and covers ID verification, passive liveness, face matching and device/IP analysis. More importantly for procurement, Didit's telehealth page says a Business Associate Agreement is included with paid plans. Obtain the actual agreement for your service and data flow before handling protected health information.

There is a practical patient-facing detail in the liveness documentation: correctable capture problems can prompt guidance and another attempt. Manual-review tools can request selected steps again. A patient struggling with lighting should have a route to fix that problem; the service still needs a human fallback for someone who cannot complete capture.

Didit also documents retention settings and a distinct privacy-erasure process. Review those alongside the organization's model-training preference, which is enabled by default and can be switched off. These controls give the privacy team concrete settings to assess instead of relying on a badge or a promise that no sensitive information is ever retained.

That combination—published costs, returning-user checks, recovery tools and an advertised BAA—makes Didit a stronger candidate than its headline price alone suggests.

• Pros: Separate onboarding and reauthentication flows, corrective capture feedback, and advertised BAA inclusion on paid plans.
• Cons: The deployment needs an agreed BAA scope, retention policy and model-training setting before patient data is used.

2. Persona: healthcare-specific claims to inspect

Persona's digital-health page explicitly describes patient verification and advertises BAA support. That is a meaningful procurement signal because it addresses questions a generic identity-verification page may leave unanswered. It remains a vendor statement, not confirmation that your proposed deployment is covered.

Ask which services the agreement includes and how the implementation separates identity proofing from access authorization. A parent, caregiver or other representative may have a legitimate role without being the person named on the patient's record. Your policy must account for that relationship.

Persona deserves a close look when the procurement team needs a supplier already speaking in healthcare terms. Bring the patient journey into the contract discussion: who gets verified, whose data is involved, and who helps when the normal route fails.

• Pros: Healthcare-specific material explicitly advertises BAA support.
• Cons: The agreement still needs to cover the exact services and data flow.

3. Jumio: onboarding and returning-user scenarios

Jumio's healthcare material covers both patient onboarding and biometric checks for returning users. That second journey deserves its own demonstration.

Consider a patient who registered months ago and now needs to recover an account after losing a phone. What should they be asked to repeat? What can the service recover from its existing records? Where does human help enter? Work through that scenario with Jumio against the proposed products and contract. The aim is a defensible recovery process that lets the care team explain each step, rather than simply sending everyone back through the original registration flow.

• Pros: Healthcare material covers onboarding and returning-user verification.
• Cons: The applicable products and health-data terms still need confirmation.

4. Veriff: assess the complete patient experience

Veriff offers document and biometric verification, with a public self-service entry plan. This makes it possible to investigate an initial commercial configuration without assuming every requirement must begin with a custom enterprise quotation.

The patient experience still needs specific testing. Consider a person with an older phone, someone unable to position a document reliably and someone who needs assistance in another language. Give those people a place in the pilot instead of assuming a successful staff demonstration represents them.

With Veriff, establish what happens after the standard flow stops helping. Who owns the exception, what can they see, and how does the patient reach them? Confirm the health-data terms for that arrangement alongside the initial plan.

• Pros: A public entry plan provides a starting commercial configuration.
• Cons: Patient fallback, support and health-data terms require separate assessment.

5. Entrust Identity Verification: define the required scope

Entrust Identity Verification, formerly Onfido IDV, offers document and biometric checks within a wider identity portfolio. That may warrant a conversation in an organization coordinating patient onboarding with other identity projects.

Draw three separate journeys before that meeting: a patient opening an account, an employee accessing work systems, and a caregiver seeking access on someone else's behalf. They involve different evidence and permissions. A shared supplier may simplify purchasing, but the service still needs an owner and a support route for each journey. Ask the proposal to show those boundaries rather than treating “healthcare identity” as one task.

• Pros: A broad identity offering for organizations considering several use cases.
• Cons: Patient, staff and caregiver requirements still need separate policies.

6. Sumsub: avoid importing unnecessary financial checks

Sumsub's published plans separate basic verification from packages with additional checks, including AML and proof-of-address features. That distinction is useful when assessing which capabilities have a real purpose in a health workflow.

A telehealth signup is not automatically the same as onboarding a financial-services customer. Start with the care organization's requirements and identify the minimum justified evidence. Do not add a financial-compliance step merely because it appears in a larger package.

Our preference would be the smallest justified set of checks. For each field, someone should be able to explain why it is needed and what decision it changes. That exercise makes the Sumsub package discussion more useful and the patient journey easier to explain.

• Pros: Distinct packages help separate basic verification from additional checks.
• Cons: Financial-compliance extras may add unnecessary steps to a care journey.

7. iDenfy: examine the exception-handling model

iDenfy's API, SDK and no-code options give a care service several implementation routes. Manual review is among the selected extras. For this audience, the central question is who gets to see the identity evidence when automation cannot finish the job.

Walk through an assisted case with the people who would handle it. Establish their access, the information they actually need, and how they return an answer to the patient. Include retention and deletion in that discussion. The final quote should describe the review service clearly enough that the care team can explain who is involved; confirm the calculation in writing rather than relying on the inconsistent calculator totals observed during research.

• Pros: Several integration options, with manual review available as an extra.
• Cons: Review access, retention and final costs need written clarification.

Separate identity, authority and record matching

HHS explains that covered entities must verify a requester's identity and authority when required and not already known. Its guidance on electronic information exchange does not prescribe one universal document-and-selfie workflow. Treat that distinction as a reason to define the task carefully, rather than to buy the largest possible check bundle.

For example, verifying a caregiver's identity does not prove permission to view an adult patient's record. Likewise, a matching name does not necessarily resolve which clinical record should be linked to an account. Document the separate authorization and matching steps, the staff responsible for exceptions and the evidence retained for each decision.

These boundaries should be reflected in the product's event model. A verification result should not silently become permission to expose clinical data. Our guide to real-time analytics in digital-health applications discusses why data and operational decisions need explicit ownership.

Resolve the contract before the patient-data pilot

Under HHS guidance, HIPAA applies to covered entities and business associates, and a covered entity engaging a business associate generally needs an appropriate written agreement. Use the HHS explanation of these roles to frame the assessment with the organization's responsible advisers.

Map exactly what would leave the application: identity images, contact details, a patient reference, appointment context or other information. Determine the vendor's role from that data flow. Do not assume that removing a diagnosis automatically settles whether information is protected health information.

For the selected arrangement, request written answers covering permitted use, subcontractors, retention, deletion, incident notification and access by support personnel. A general information-security certification is useful evidence, but it does not replace a required agreement. Resolve those terms for the selected services before sending patient information.

Evaluate access as carefully as fraud controls

Run an authorized pilot with representative devices and permitted test participants. Measure completion, abandonment, requests for assistance and the time needed to resolve exceptions. A provider's fast processing claim does not describe the whole patient experience.

Design an alternative route for people who cannot complete the normal capture process. Explain how they can reach help and who can make the next decision. Avoid making an automated failure look like a clinical determination. The digital-health equity measurement guide provides a useful framework for identifying who a product leaves behind.

Ask separately for current evidence on presentation and injection attacks, including test scope and product version. Do not turn a general liveness claim into a guarantee against every AI-assisted attack. Procurement should examine both fraud resistance and legitimate-patient access.

What should the final shortlist decision say?

The final decision should be understandable to the person running the service: why this provider, what information it receives, who can see it, and what happens when a patient needs help. We would start the commercial and technical evaluation with Didit, then let mandatory healthcare requirements determine which candidates can proceed.

For a broader assessment of the product and operating model, explore mHealth Zone's industry analysis. The goal is a justified identity process that fits the care journey, with responsibilities clear before deployment.